StockData
BioRestorative Therapies, Inc. logo

BioRestorative Therapies, Inc. (BRTX) stock

BRTXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 14, 2026Score 8/30
$1.32−0.02 (-1.12%)

Close on Nov 18, 2026Market cap $33.76MP/E –Yield –

BioRestorative Therapies revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

BioRestorative Therapies's revenue for the twelve months ending Mar 31, 2026 was $357.87K, down 8.5% year over year. For fiscal 2025 it was $359.70K, down 10.3% from the year before. Over ten years it grew -5.4% a year on average. The highest annual figure on record is $628.92K in fiscal 2015.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$359.70K-10.3%
FY2024Dec 31, 2024$401.00K+175.0%
FY2023Dec 31, 2023$145.80K+21.7%
FY2022Dec 31, 2022$119.80K+160.4%
FY2021Dec 31, 2021$46.00K-40.3%
FY2020Dec 31, 2020$77.00K-40.8%
FY2019Dec 31, 2019$130.00K+17.1%
FY2018Dec 31, 2018$111.00K+37.0%
FY2017Dec 31, 2017$81.00K+122.8%
FY2016Dec 31, 2016$36.36K-94.2%
FY2015Dec 31, 2015$628.92K+51.2%
FY2014Dec 31, 2014$416.00K+24661.7%
FY2013Dec 31, 2013$1.68K-89.2%
FY2012Dec 31, 2012$15.59K–
FY2011Dec 31, 2011$0–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2026Mar 31, 2026$23.17K-7.3%
Q4 FY2025Dec 31, 2025$19.60K-54.7%
Q3 FY2025Sep 30, 2025$11.80K-94.9%
Q2 FY2025Jun 30, 2025$303.30K+240.4%
Q1 FY2025Mar 31, 2025$25.00K-28.6%
Q4 FY2024Dec 31, 2024$43.30K+124.4%
Q3 FY2024Sep 30, 2024$233.60K+660.9%
Q2 FY2024Jun 30, 2024$89.10K+38.1%
Q1 FY2024Mar 31, 2024$35.00K+11.8%
Q4 FY2023Dec 31, 2023$19.30K+421.6%
Q3 FY2023Sep 30, 2023$30.70K+5.9%
Q2 FY2023Jun 30, 2023$64.50K-9.3%
Q1 FY2023Mar 31, 2023$31.30K+95.6%
Q4 FY2022Dec 31, 2022$3.70K-26.0%
Q3 FY2022Sep 30, 2022$29.00K+262.5%
Q2 FY2022Jun 30, 2022$71.10K+374.0%
Q1 FY2022Mar 31, 2022$16.00K-11.1%
Q4 FY2021Dec 31, 2021$5.00K-70.6%
Q3 FY2021Sep 30, 2021$8.00K-46.7%
Q2 FY2021Jun 30, 2021$15.00K-21.1%
Q1 FY2021Mar 31, 2021$18.00K-30.8%
Q4 FY2020Dec 31, 2020$17.00K-46.9%
Q3 FY2020Sep 30, 2020$15.00K-60.5%
Q2 FY2020Jun 30, 2020$19.00K-38.7%
Q1 FY2020Mar 31, 2020$26.00K-10.3%
Q4 FY2019Dec 31, 2019$32.00K+10.3%
Q3 FY2019Sep 30, 2019$38.00K+46.2%
Q2 FY2019Jun 30, 2019$31.00K-16.2%
Q1 FY2019Mar 31, 2019$29.00K+52.6%
Q4 FY2018Dec 31, 2018$29.00K-23.7%
Q3 FY2018Sep 30, 2018$26.00K+62.5%
Q2 FY2018Jun 30, 2018$37.00K+85.0%
Q1 FY2018Mar 31, 2018$19.00K+171.4%
Q4 FY2017Dec 31, 2017$38.00K+525.5%
Q3 FY2017Sep 30, 2017$16.00K+220.0%
Q2 FY2017Jun 30, 2017$20.00K+23.8%
Q1 FY2017Mar 31, 2017$7.00K–
Q4 FY2016Dec 31, 2016$6.08K–
Q3 FY2016Sep 30, 2016$5.00K–
Q2 FY2016Jun 30, 2016$16.16K–

More BioRestorative Therapies figures

See a number that looks wrong?